Abstract
Oral squamous cell carcinoma (OSCC) is one of the major leading causes of cancer-related death worldwide, with limited effective markers for diagnosis and therapy, which has caused a low overall survival rate in the past decades. Kinases play important roles in tumor development and malignancy in various types of cancer. However, little is known about the role of kinases in OSCC cells. In this study, an arrayed kinome small interfering RNA (siRNA) library was used to screen oral cancer cell lines and counter assayed with normal fibroblast cells to identify the genes required for cancer cell proliferation. We found that polo-like kinase 1 (PLK1) was one of the most potent genes required for OSCC cell proliferation. The knockdown of PLK1 with a siRNA or antisense oligonucleotide (ASO) consistently diminished cyclin-B1 (CCNB1) expression/phosphorylation and the G2-M phase transition. Similar effects were observed in cells treated with the PLK1 kinase inhibitor BI6727. Besides, The Cancer Genome Atlas (TCGA) analysis revealed that PLK1 was elevated in tumor tissues and associated with short survival in patients with OSCC. We also found that PLK1 expression was highly correlated with the expression of its downstream effector, CCNB1,...Continue Reading
References
Nov 10, 2000·Nucleic Acids Research·K KrauseK Engeland
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Nov 10, 2011·The Journal of Pathology·Jonathan K Watts, David R Corey
Nov 26, 2011·Cell Death and Differentiation·M BartucciR De Maria
Jun 16, 2012·British Journal of Cancer·K MrossM E Scheulen
Apr 25, 2013·International Journal of Cancer. Journal International Du Cancer·Youwei Zhang, Tony Hunter
Sep 10, 2013·Cell Cycle·Khanh DoShivaani Kummar
Oct 22, 2013·Pharmacology & Therapeutics·S McNeelyA K Bence Lin
Dec 3, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Sree Vidya Krishna RaoRichard Logan
Dec 18, 2013·Cancer·Walter M StadlerMichael A Carducci
Jun 23, 2016·Molecular Cancer Therapeutics·Rosie Elizabeth Ann GutteridgeNihal Ahmad
Jun 24, 2016·The Korean Journal of Internal Medicine·Sung-Eun LeeDong-Wook Kim
Jul 8, 2016·Oncotarget·Joon Hee KangSoo-Youl Kim
Jul 19, 2016·Trends in Pharmacological Sciences·Christopher J MathesonPhilip Reigan
Aug 30, 2016·Postdoc Journal : a Journal of Postdoctoral Research and Postdoctoral Affairs·Jessica Chery
Nov 24, 2016·Journal of Cellular and Molecular Medicine·Zhe ZhangChuize Kong
Nov 27, 2016·Translational Oncology·Zhixian LiuXiaosheng Wang
Apr 28, 2017·Cancers·Stuart RundleNicola J Curtin
Jan 19, 2018·Theranostics·Pei-Feng LiuChih-Wen Shu
Nov 27, 2018·Frontiers in Pharmacology·Yen-Dun Tony TzengChih-Wen Shu
Apr 26, 2019·Disease Markers·Gabriele CervinoMarco Cicciù
Jun 20, 2019·Frontiers in Oncology·Jin-Shiung ChengChih-Wen Shu
Citations
May 29, 2020·Journal of Cellular and Molecular Medicine·Yu ChenJun Li
Sep 5, 2020·Journal of Drug Targeting·Ilma ShakeelMd Imtaiyaz Hassan
Nov 28, 2019·Cancers·Pei-Feng LiuChih-Wen Shu
Mar 23, 2021·Environmental Toxicology·Chih-Wen ShuChing-Yu Yen
Jun 3, 2021·Cancers·Annouk S PierikRuud H Brakenhoff